Chat with us
About Us
Who We Are
Infinata enables clients to turn information into insight, featuring a distinguished suite of intelligence solutions for the global biopharma and wealth prospecting communities, as well as enterprise-class custom data services. From global biopharmaceutical companies and leading CROs to individual asset managers and national banks, Infinata delivers flexible solutions and unrivaled personal support to provide clients an information edge.
Incorporated in 1999 and headquartered in Boston with offices in New York, London, and Hong Kong, Infinata is a wholly-owned subsidiary of Mergermarket, a part of the Financial Times Group and a division of Pearson plc.